Thrombolytic therapy of acute pulmonary embolism: current status and future potential (Q39597700)

13 September 2017

1 reference

title

Thrombolytic therapy of acute pulmonary embolism: current status and future potential (English)

1 reference

13 September 2017

1 reference

S Z Goldhaber

1

1 reference

13 September 2017

M F Meyerovitz

2

1 reference

13 September 2017

J E Markis

3

1 reference

13 September 2017

D Kim

4

1 reference

13 September 2017

C M Kessler

5

1 reference

13 September 2017

G V Sharma

6

1 reference

13 September 2017

D E Vaughan

7

1 reference

13 September 2017

A P Selwyn

8

1 reference

13 September 2017

D L Dawley

9

1 reference

13 September 2017

J Loscalzo

10

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 November 1987

1 reference

Journal of the American College of Cardiology

13 September 2017

published in

1 reference

13 September 2017

volume

10

1 reference

13 September 2017

issue

5 Suppl B

1 reference

13 September 2017

page(s)

96B-104B

1 reference

Thrombolytic therapy in thrombosis: a National Institutes of Health consensus development conference

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980434-5

7 January 2021

Comparison by Controlled Clinical Trial of Streptokinase and Heparin in Treatment of Life-threatening Pulmonary Embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980434-5

7 January 2021

A Controlled Clinical Trial of Streptokinase and Heparin in the Treatment of Major Pulmonary Embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980434-5

7 January 2021

Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980434-5

7 January 2021

Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980434-5

7 January 2021

A comparison of the thrombolytic and hemorrhagic effects of tissue-type plasminogen activator and streptokinase in rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980434-5

7 January 2021

Thrombolysis by human tissue plasminogen activator and urokinase in rabbits with experimental pulmonary embolus

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980434-5

7 January 2021

Specific lysis of an iliofemoral thrombus by administration of extrinsic (tissue-type) plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980434-5

7 January 2021

Thrombolytic treatment with recombinant tissue-type plasminogen activator in a patient with massive pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980434-5

7 January 2021

Acute pulmonary embolism treated with tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980434-5

7 January 2021

Perspectives on treatment of acute pulmonary embolism with tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980434-5

7 January 2021

Pulmonary perfusion after rt-PA therapy for acute embolism: early improvement assessed with segmental perfusion scanning

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980434-5

7 January 2021

Early reversal of right ventricular dysfunction in patients with acute pulmonary embolism after treatment with intravenous tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980434-5

7 January 2021

Synergism of thrombolytic agents in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980434-5

7 January 2021

A comparative study of the efficacy and specificity of tissue plasminogen activator and pro-urokinase: demonstration of synergism and of different thresholds of non-selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980434-5

7 January 2021

Coronary thrombolysis in patients with acute myocardial infarction by intravenous infusion of synergic thrombolytic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980434-5

7 January 2021

10.1016/S0735-1097(87)80434-5

Identifiers

DOI

1 reference

13 September 2017

1 reference